September 29, 2016 Columns by Laura Kolaczkowski Thinking, Hands, and MS! ECTRIMS 2016 (European Committee for Treatment and Research in MS) produced lots of stories with exciting headlines about advances in MS research — and hopefully you read many of them here at MS News Today. As I went…
September 19, 2016 Columns by Laura Kolaczkowski EpiPen and MS Drugs If only we were cherub faced children, then perhaps someone would have listened to us in the past few years as we voiced concern and then outrage over the escalating costs of our MS disease modifying therapy (DMT) drugs.
September 13, 2016 by Laura Kolaczkowski Lack of Diversity Hurts MS Studies The importance of getting a representative group of people, also known as subjects, engaged in clinical trials cannot be understated. There is so much that we need to know when it comes to multiple sclerosis, but the picture…
September 6, 2016 Columns by Laura Kolaczkowski The Doctor Doesn’t Always Know Best There was an almost audible gasp in the room as I was making a presentation recently at a multiple sclerosis talk. What did I say that was so shocking? I merely said – if you don’t agree with your…
August 29, 2016 Columns by Laura Kolaczkowski Wait! Here’s a Pill for Your MS Most of us with MS rely on pharmacological assistance to make it through the day. I know taking pills by the handful is the regimen of many people, whether they are sick with multiple sclerosis or one of…
August 22, 2016 Columns by Laura Kolaczkowski HSCT as MS Therapy: An American’s Tale Karen Staman and I met a while back through a National Institute of Health and Duke University research collaborative effort. She is a scientific writer by trade, which means she sits through lots of conversation and puts everyone…
August 15, 2016 Columns by Laura Kolaczkowski REAL MS Research Needs You You want to help find answers about multiple sclerosis but don’t know how, and I hear your frustration about being unable to contribute in meaningful ways. Let me share with you the news that REAL MS (Research…
August 5, 2016 Columns by Laura Kolaczkowski Hospitality Care Service for Clinical Trial Participants This idea is so simple. But it has been overlooked for years until the partners of Gray Consulting, a Philadelphia firm, connected the dots and developed a better way to engage and retain people in clinical trials. Scott…
August 1, 2016 Columns by Laura Kolaczkowski FICO Enters Healthcare Arena with Treatment Adherence Scores Do you take your drugs as they are prescribed? It turns out a lot of us don’t and that is a concern to the people in charge of our healthcare dollars. The California Association of Health Plans estimates that…
July 25, 2016 Columns by Laura Kolaczkowski MS BLOG: Sort Anecdotal Claims, Real Science Before Research Treatments Can we all agree that research studies are important and they are necessary to prove whether a concept works or it doesn’t? Even from the biggest failures, we can learn more. We can also all agree that research has…
July 18, 2016 Columns by Laura Kolaczkowski Phase 1 Clinical Trials – An Early, But Key Step, in Drug-approval Process We wait in anticipation for multiple sclerosis (MS) drugs to clear Phase 3 clinical trials and get to the Food and Drug Administration (FDA) for approval, but I honesty knew little of the process that takes place before the…
July 13, 2016 Columns by Laura Kolaczkowski Patient Recruitment for Clinical Trials: Something To Chew On This chewing gum handout in the exhibit area of the recent Drug Information Association (DIA) 2016 meeting says it all from the pharmaceutical company perspective – recruiting patients for their studies is often a distasteful and difficult process. While…
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis